Determinations of elevated ALAT activity in serum and plasma are mainly used to aid in the diagnosis and monitor of liver diseases e.g. acute hepatitis, hepatocyte necrosis, hepatic ischemia, cirrhosis, cholestasis, liver tumor, hepatotoxic drugs, mechanical jaundice. Increased levels of ALAT can be observed in severe burns, striated muscle injury, muscle inflammation, pancreatitis, myocardial infarction, infectious mononucleosis, trauma, patients with higher risk of COVID-19 adverse outcome.
Specification
Method according to International Federation of Clinical Chemistry (IFCC), without pyridoxal phosphate
Specimen serum
On board stability up to 12 weeks
Calibration stability up to 12 weeks
Measuring range linear up to 1200 U/l
Regulatory status CE IVD